Paramount Peptides
Retatrutide
Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR antagonist) from Paramount Peptides between 14 Jan 2025 and 20 Mar 2025. Tests score average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).
Finnrick Rating™
Paramount Peptides
Retatrutide
Tested 6 Samples
Last test 20 Mar 2025
Take Action
Mail in a Sample
We test your peptides for free: mail in a sample you have (US only), or request us to test a vendor.
Retatrutide is also available from top-rated vendors:
All Retatrutide tests from Paramount Peptides
Samples are tested in commercial labs
Tests Count
6
Scores
AVGMINMAX
Last
20 Mar 2025
First
14 Jan 2025
| Quantity | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Test Date | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 20 Mar 2025 | 12mg | 11.860mg | -1.2% | 99.52% | RET12N11142004 | Blue Label / Clear Cap | Lab B | Finnrick | |
| 28 Feb 2025 | 12mg | 11.449mg | -4.6% | 99.49% | RET12N11142004 | Blue Label / Clear Cap | Lab C | Finnrick | |
| 28 Feb 2025 | 12mg | 11.462mg | -4.5% | 99.64% | RET12N11142004 | Blue Label / Clear Cap | Lab C | Finnrick | |
| 27 Feb 2025 | 12mg | 10.740mg | -10.5% | 99.83% | RET12N11142004 | Blue Label / Clear Cap | Lab A | Finnrick | |
| 23 Jan 2025 | 12mg | 15.200mg | +26.7% | 99.67% | (no batch ID) | (no data) | Lab B | Finnrick | |
| 14 Jan 2025 | 12mg | 13.410mg | +11.8% | 99.88% | (no batch ID) | (no data) | Lab A | Finnrick | |